Literature DB >> 28702852

Pilot Test of an Integrated Sexual Risk Reduction Intervention for Women with a History of Childhood Sexual Abuse.

Theresa E Senn1, Amy Braksmajer1, Marguerite A Urban2,3, Patricia Coury-Doniger1, Michael P Carey4,5,6.   

Abstract

HIV and childhood sexual abuse (CSA) are intersecting public health problems for women. We pilot tested an integrated sexual risk reduction intervention for women with a history of CSA that addressed both the consequences of CSA [based on the Traumagenic Dynamics (TD) framework] and the antecedents of sexual risk behavior (based on the Information-Motivation-Behavioral Skills [IMB] model). Women with a history of CSA who were attending a public STI clinic (n = 84) were randomly assigned to a five-session integrated TD/IMB (experimental) group intervention or to a time-matched IMB-guided sexual risk reduction (control) group intervention. Preliminary findings indicated that women in the integrated TD/IMB intervention reduced their average number of episodes of unprotected sex with a primary partner, their alcohol use, and their likelihood of being in a violent relationship, relative to women in the IMB-only group. Our findings suggest that sexual risk reduction interventions that address both the consequences of CSA and the antecedents of sexual risk behavior may be efficacious in reducing sexual risk behavior among women who were sexually abused.

Entities:  

Keywords:  Childhood sexual abuse; HIV; IMB model; Intimate partner violence; Sexual risk reduction intervention; Traumagenic dynamics

Mesh:

Year:  2017        PMID: 28702852     DOI: 10.1007/s10461-017-1854-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  1 in total

1.  Profiling Children Sexual Abuse in a Sample of University Students: A Study on Characteristic of Victims, Abusers, and Abuse Episodes.

Authors:  Angel Castro; José David Moreno; Berta Maté; Javier Ibáñez-Vidal; Juan Ramón Barrada
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.